Protocol no. P2-86893-001 (SURPH trial) – Allgenesis Biotherapeutics Australia Pty. Ltd.

Protocol no. P2-86893-001 (SURPH trial) – Allgenesis Biotherapeutics Australia Pty. Ltd.

A multicentre, prospective, randomised, double-masked, Phase 2 study evaluating the safety, tolerability and efficacy of topical AG-86893 in patients with Pterygium.

Trial Registry Number: NCT03533244

Need any help?

If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.

Request an appointment